Work

Inhibition of Osteolytic Bone Lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (a.p.d.)

Year: 1979
Type: article
Study design: Clinical Trial
Source: The Lancet
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W2083334726
FWCI: 13.88
Cites: 5
Cited by: 172
Related to: 9